Apoptosis in serum of patients with solid tumours

Citation
S. Holdenrieder et al., Apoptosis in serum of patients with solid tumours, ANTICANC R, 19(4A), 1999, pp. 2721-2724
Citations number
10
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
19
Issue
4A
Year of publication
1999
Pages
2721 - 2724
Database
ISI
SICI code
0250-7005(199907/08)19:4A<2721:AISOPW>2.0.ZU;2-4
Abstract
Apoptosis, which occurs in highly proliferating tumours spontaneously or du ring anticancer herapy, may lead to an elevated concentration of circulatin g nucleosomes in! blood. In order to quantify the concentration of nucleoso mes, lye used the Cell Death Detection(plus) ELISA (CDDE) (Boehringer Mannh eim, Germany) based on antibodies against histone and DNA, adapted it to th e demands of liquid materials and standardized test performance and handlin g of serum. Furthermore, we investigated serum samples of 185 patients with solid tumours (additionally 24, treated with radio- or chemotherapy), 30 w ith acute inflammations and 50 healthy persons. Many patients with tumours (78%) and inflammations (77%) showed higher concentrations of serum-nucleos omes (>100 AU), whereas 96% of all healthy persons had low values (<100 AU) . Follow up-studies revealed an early peak after initiation of therapy and correlated to the clinical outcome. The concentration of nucleosomes is a s ensitive marker of cell death and could be used for monitoring the efficacy of antitumour therapy.